Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lümeisi Tablet (II) vs enteric-coated aspirin in thrombosis-related cardiovascular and cerebrovascular disease
CTR20130793Phase 2Completed
- Sponsor
- Xi'an Bohua Pharmaceutical
- Start
- Apr 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aspirin in angina pectoris, myocardial infarction (MI), transient ischaemic attack (TIA), brain infarction, thrombosis, sponsored by Xi'an Bohua Pharmaceutical. Started Apr 2014; status: completed.
02
Drugs
aspirin
03
Conditions
angina pectorismyocardial infarction (MI)transient ischaemic attack (TIA)brain infarctionthrombosis
Beyond the preview
Go deeper on CTR20130793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130793.